McCloud and pension tax – what urgent action do NHS pension members need to take?
Technical team lead at Wesleyan, Madeleine Dowling, explores what urgent action NHS pension members need to take
Related Articles
Cancer Blogs | Cancer Patient Stories | CURE
CURE® provides a space that highlights the voices of patients with cancer, survivors, caregivers, and advocates. Read personal stories on CURE’s blog page.
Community nurses helping ease winter ambulance pressures
Community nurses have been introduced to an ambulance control room to link-up services and improve response times this winter.
Magrolimab-Chemo Combo Improves Responses in Metastatic NSCLC
Patients with metastatic non-small cell lung cancer and high CD47 expression showed improved responses to treatment with magrolimab plus docetaxel.
Children and young people should be involved in the development of health technologies
Commentary on: Court RJ, et al . Children and young people’s preferences and needs when using health technology to self-manage a long-term condition: a scoping…
Subcutaneous Opdivo Receives FDA Approval for Advanced, Metastatic Solid Tumors
Opdivo Qvantig received FDA approval for all previously approved indications in solid tumors.
FDA Approves Tevimbra Plus Chemo for Gastric, Gastroesophageal Junction Adenocarcinoma
This marks the second FDA approval of Tevimbra this year.
Family Resilience in Patients With Schizophrenia: Potential Influencing Factors and Mediating Effect
Objective To identify the determinants of family resilience in the recovery of individuals with schizophrenia using Walsh’s family resilience framework. Design A cross-sectional study. Methods…
The importance of primary care practice placements for students
Lucille Kelsall-Knight reflects on the shortfall in general practice nurses and student placements in primary care.
Real-World Use of Ide-cel Provides Favorable Outcomes in CNS Myeloma
Patients treated with ide-cel, Abecma for relapsed/refractory multiple myeloma affecting the central nervous system had similar outcomes to matched patients with non-CNS multiple myeloma.
Calquence Plus Venclexta Combo May Improve Survival in Frontline CLL
Calquence plus Venclexta, with or without Gazyva, improved progression-free survival over the standard-of-care chemoimmunotherapy in patients with untreated chronic lymphocytic leukemia.